Please check your internet connection and try again.
# Diclofenac (Oral)
## Overview
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation.
## Primary Indications
* Pain (mild to moderate)
* Inflammatory conditions (e.g., osteoarthritis, rheumatoid arthritis)
## Adult Dosing
* **Immediate-release:** 50 mg two to three times daily. Maximum daily dose: 150 mg.
* **Delayed-release:** 75 mg twice daily. Maximum daily dose: 150 mg.
* **Extended-release:** 100 mg once daily or 75 mg twice daily. Maximum daily dose: 100 mg for once-daily dosing, 150 mg for twice-daily dosing.
Dosing should be titrated to the lowest effective dose.
## Pediatric Dosing
* **Pain and inflammation (ages 1 to 12 years):** 1-3 mg/kg/day divided into 2-3 doses. Maximum daily dose: 4 mg/kg/day or 150 mg/day, whichever is less. *Specific dosing depends on local protocol and indication.*
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Maximum daily dose should be reduced. Avoid if severe hepatic impairment.
* **Renal Impairment:** Use with caution. Avoid in severe renal impairment.
## Contraindications
* Hypersensitivity to diclofenac, aspirin, or other NSAIDs.
* History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
* Inflammatory bowel disease (active or history).
* Congestive heart failure.
* Third trimester of pregnancy.
## Adverse Effects
* **Common:** Abdominal pain, nausea, dyspepsia, diarrhea, constipation, dizziness, headache, elevated liver enzymes.
* **Serious:** Gastrointestinal bleeding, ulceration, perforation; cardiovascular thrombotic events (MI, stroke); renal toxicity; hepatic toxicity; hypertension; fluid retention; hypersensitivity reactions.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin):** Increased risk of bleeding.
* **Corticosteroids:** Increased risk of GI ulceration/bleeding.
* **SSRIs/SNRIs:** Increased risk of GI bleeding.
* **Diuretics, ACE inhibitors, ARBs:** Reduced antihypertensive effect, increased risk of renal impairment.
* **Lithium, Methotrexate:** Increased serum levels and toxicity.
## Monitoring
* **Baseline and periodic:** Renal function (BUN, creatinine), liver function tests (ALT, AST), complete blood count (CBC).
* **With prolonged use:** Assess for signs/symptoms of GI bleeding, cardiovascular events, and renal/hepatic dysfunction.
## Clinical Pearls
* Administer with food or milk to minimize GI upset.
* Use the lowest effective dose for the shortest duration necessary.
* Consider gastroprotective agents (e.g., PPIs) in patients at high risk for GI complications.
* NSAIDs can mask signs of infection.
* Withdrawal of NSAIDs may unmask signs of renal disease.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines before making clinical decisions. Dosing may vary based on patient-specific factors and local protocols.